- Report
- January 2022
- 79 Pages
Global
From €808EUR$850USD£679GBP
- Report
- July 2022
- 159 Pages
Global
From €2234EUR$2,350USD£1,877GBP
- Report
- December 2023
- 100 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 147 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- October 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 70 Pages
Egypt
From €3327EUR$3,500USD£2,795GBP
From €3327EUR$3,500USD£2,795GBP
- Report
- February 2023
- 79 Pages
Saudi Arabia
From €3327EUR$3,500USD£2,795GBP
- Report
- September 2024
- 82 Pages
India
From €3327EUR$3,500USD£2,795GBP
- Report
- April 2023
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 120 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 112 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- October 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- June 2023
- 33 Pages
Global
From €1854EUR$1,950USD£1,557GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4706EUR$4,950USD£3,953GBP
- Report
- August 2022
- 35 Pages
Global
From €1854EUR$1,950USD£1,557GBP
- Report
- January 2023
- 220 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- December 2022
- 122 Pages
North America
From €3280EUR$3,450USD£2,755GBP
- Report
- December 2022
- 137 Pages
Europe
From €3280EUR$3,450USD£2,755GBP

Asthma is a chronic respiratory condition that affects the airways of the lungs. It is characterized by inflammation, narrowing of the airways, and increased mucus production, which can lead to difficulty breathing, wheezing, and coughing. Asthma is one of the most common chronic diseases in the world, and is a major cause of morbidity and mortality.
The asthma market within the context of pulmonary medicine is a rapidly growing sector, with a wide range of products and services available to treat and manage the condition. These include inhalers, nebulizers, and other devices to deliver medication, as well as monitoring and diagnostic tools. In addition, there are a variety of medications available to treat asthma, including corticosteroids, bronchodilators, and leukotriene modifiers.
Some of the major companies in the asthma market include GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, and AstraZeneca. Show Less Read more